Diabetes mellitus is rapidly becoming one of the predominant health concerns of the western world. Fundamentally, diabetes is a failure of the insulin signaling system which functions to maintain blood glucose concentrations within a narrow range. A key component of this system is the pancreatic beta-cell which singularly has responsibility for insulin production and secretion. For proper function, the pancreatic beta-cell is required to make and release large amounts of insulin in response to elevated blood glucose. The subject of this proposal is a system of the beta-cell that increases insulin production in response to elevated blood glucose. We have recently discovered that PASK is an important part of this system at least in isolated beta-cells in the laboratory. The goals of the current proposal are threefold. First, we will study how PASK activity is regulated by glucose concentration. Second, we will determine how PASK stimulates insulin production. Specifically, what other proteins are involved and how does PASK control their function. Third, we will use mice in which PASK has been eliminated to assess the importance of this protein in the natural function of beta-cells. We will examine these mice for defects in the development, maintenance and insulin production of beta-cells. In a larger context, we will examine the mice for global defects that are characteristic of inadequate beta-cell function, such as overt diabetes. We hope to further the understanding of this important beta-cell system for responding to increased blood glucose, and specifically the role of PASK in its operation. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK071962-04
Application #
7459094
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Appel, Michael C
Project Start
2005-09-01
Project End
2009-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
4
Fiscal Year
2008
Total Cost
$244,351
Indirect Cost
Name
University of Utah
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Wu, Xiaoying; Romero, Donna; Swiatek, Wojciech I et al. (2014) PAS kinase drives lipogenesis through SREBP-1 maturation. Cell Rep 8:242-55
Schell, John C; Olson, Kristofor A; Jiang, Lei et al. (2014) A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell 56:400-13
Semache, Meriem; Zarrouki, Bader; Fontés, Ghislaine et al. (2013) Per-Arnt-Sim kinase regulates pancreatic duodenal homeobox-1 protein stability via phosphorylation of glycogen synthase kinase 3? in pancreatic ?-cells. J Biol Chem 288:24825-33
Orsak, Thomas; Smith, Tammy L; Eckert, Debbie et al. (2012) Revealing the allosterome: systematic identification of metabolite-protein interactions. Biochemistry 51:225-32
Cardon, Caleb M; Rutter, Jared (2012) PAS kinase: integrating nutrient sensing with nutrient partitioning. Semin Cell Dev Biol 23:626-30
Bricker, Daniel K; Taylor, Eric B; Schell, John C et al. (2012) A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337:96-100
Cardon, Caleb M; Beck, Thomas; Hall, Michael N et al. (2012) PAS kinase promotes cell survival and growth through activation of Rho1. Sci Signal 5:ra9
Semplici, Francesca; Vaxillaire, Martine; Fogarty, Sarah et al. (2011) Human mutation within Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion. J Biol Chem 286:44005-14
Leclerc, I; Sun, G; Morris, C et al. (2011) AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells. Diabetologia 54:125-34
Mbaya, E; Oulès, B; Caspersen, C et al. (2010) Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency. Cell Death Differ 17:1855-66

Showing the most recent 10 out of 29 publications